Early Access — free while we kick the tires
EdgarHawk

Radoff Bradley Louis

Director

Director 10% Owner
9 filings analyzed · 3 companies · Latest 2026-02-12

Companies

Company Buys Sells Direction
KVH INDUSTRIES INC \DE\ KVHI 9 0 Net buying
HARTE HANKS INC HHS 44 0 Net buying
Guardion Health Sciences, Inc. GHSI 0 4 Net selling

Activity

February 2026
medium
Buy
30,000 shares
$187,944
Significance 5/10

10% owner Radoff Bradley Louis buys 30,000 shares of KVHI at $6.26; stock down 14.6% in 30 days from purchase.

Radoff Bradley Louis, a 10% owner, purchased 30,000 shares at $6.26 on 2026-02-12, bringing his holdings to 2,180,000 shares. The stock has declined 14.6% over the 30 days since the purchase, now trading at $6.20, only 0.8% below the transaction price despite intraday weakness. Fundamentally, KVH Industries faces headwinds: the latest quarter revenue was $28,453,000, net income was $-6,934,000 (unprofitable), and annual revenue growth stands at -14.0%. His cross-ticker track record shows modest execution: 20 prior buys averaged -6.6% return over 30 days and -11.4% over 90 days, with a 5% win rate at the 90-day horizon. At this same ticker, his one prior purchase on 2025-11-14 delivered +19.6% in 30 days and +7.3% in 90 days, suggesting better timing discipline at KVHI specifically than across his broader portfolio.

November 2025
medium
Buy
40,000 shares
$231,180
Significance 3/10

10% owner Radoff Bradley Louis buys 40,000 shares of KVHI at $5.78; stock currently $5.63, down 9.3% from 52-week high

Radoff Bradley Louis, holding 2.15M shares (10% owner), purchased 40,000 shares at $5.78, expanding his position by 1.9%. The transaction occurred near the lower end of the 52-week range ($4.75–$6.21), with the stock currently trading at $5.63, 9.3% below its recent high. However, his cross-ticker track record across 20 prior open-market buys shows an average 90-day return of -12.3% with a 0.00% win rate, indicating a historical pattern of purchases that do not reverse course within that timeframe. KVH Industries itself faces material operational headwinds: revenue declined 14.0% year-over-year, the company posted a net loss of $6.9M in the latest quarter, and it remains unprofitable on a full-year basis with a market cap of $110.2M. This buy by a substantial shareholder in a challenged operational environment warrants examination of whether it reflects conviction in a turnaround or execution of a pre-existing trading plan.

December 2024
2024-12-06 HARTE HANKS INC HHS
high
Buy
17,225 shares
$100,389
Significance 6/10

Director Radoff Bradley Louis bought 17,225 shares at blended average $5.83, expanding stake 4.6% to 391,399 shares (12/5/24).

Radoff Bradley Louis, a Director of Harte Hanks Inc (HHS), executed 19 separate purchases totaling 17,225 shares for $100,389.22 on 2024-12-05, acquiring shares at prices ranging from $5.75 to $5.89 with a blended average of $5.83. His holdings increased from 374,174 shares to 391,399 shares post-transaction. The transaction occurred in a context of material weakness: the stock has declined 17.1% over the past 30 days and 19.1% over 90 days, trading 32.5% below its 52-week high of $8.79. Harte Hanks is operationally challenged—annual revenue declined 7.2% year-over-year, the company was unprofitable over its most recent full fiscal year, and the market cap stands at $43.2M. The multi-tranche execution pattern (19 buys across a narrow price band of $5.75–$5.89 on a single day) is notable given the company's small market cap and weak fundamentals, though outcomes from this director's five prior purchases at HHS on 2024-12-04 remain unmeasurable.

2024-12-05 HARTE HANKS INC HHS
high
Buy
42,775 shares
$241,551
Significance 6/10

HHS Director Radoff bought 42,775 shares for $241,551.15 in 22 transactions on 2024-12-04

Radoff Bradley Louis, a director at Harte Hanks Inc, executed 22 separate open-market purchases on 2024-12-04 totaling 42,775 shares for $241,551.15 at a blended average price of $5.65, increasing his holdings from 331,399 to 374,174 shares (+12.9%). The transaction occurred as the stock trades at $5.89, down 33.0% from its 52-week high of $8.79 and has declined 15.5% over the prior 30 days. The company faces structural headwinds: revenue of $47,630,000 annually is contracting at 7.2% year-over-year, and the company reported negative full-year net income, leaving a net income figure of only $142,000 for the latest quarter. The fragmented purchase pattern across multiple price points ($5.50–$5.70) suggests systematic accumulation rather than opportunistic timing. Investors should weigh this substantial insider accumulation against the company's deteriorating profitability and declining top-line growth trajectory.

November 2024
high
Buy
50,000 shares
$239,715
Significance 7/10

10% owner Radoff Bradley Louis purchased 50,000 shares (50.0K shares) across 2 transactions totaling $239.7K at blended avg $4.79, expanding holdings to 2.11M shares.

Radoff Bradley Louis, a 10% owner, executed 2 separate open-market purchases totaling 50,000 shares for $239,715.19 at prices ranging from $4.67 to $4.86, near current levels ($4.85). This transaction builds on significant recent buying activity at KVHI: the insider has made 5 open-market purchases since August 1, 2024, with 3 of the 3 measurable 90-day outcomes showing positive returns, indicating a pattern of well-timed purchases at this ticker. The company faces near-term headwinds—it is unprofitable (most recent full-year net income negative) with declining annual revenue (-4.6% year-over-year) and recent quarterly net loss of $1.2M—yet the insider continues accumulating shares. The cross-ticker track record shows 12 prior buys averaging +3.3% returns over 30 days and +7.6% over 90 days with a 70% win rate, suggesting selective execution competence, though current purchase at $4.79 is 9.8% below the 52-week high and +10.2% above 90-day lows.

September 2024
high
Buy
60,000 shares
$277,797
Significance 6/10

10% owner Radoff Bradley Louis bought 60,000 shares (60.0K shares) at $4.63 over two days; holdings rise to 325,000 shares; stock down -18.4% from 52-week high amid unprofitable operations.

Radoff Bradley Louis, a 10% owner, executed 2 separate purchases totaling 60,000 shares for $277,796.53 ($277.8K) at a blended average price of $4.63 on 2024-09-04 and 2024-09-05, increasing his holdings by 22.6% from 265,000 to 325,000 shares. This represents a concentrated accumulation by a major shareholder at a price point that is currently trading 1.5% lower ($4.56) and sits -18.4% below the 52-week high of $5.59, signaling acquisition during a period of weakness. The context is notable: KVH Industries posted negative net income of $-2.4M on quarterly revenue of $28.7M and has experienced -4.6% annual revenue decline, yet the 10% owner is expanding his position materially. Across his cross-ticker open-market history, this insider's 10 prior buys averaged +20.2% 90-day returns with a 100% win rate, though his same-ticker prior trades at KVHI (3 prior buys in August) have yet to show measurable 90-day outcomes and showed mixed 30-day results (-2.1%, +2.0%, +4.7%).

August 2024
Sell
115,540 shares
$1,626,419
Significance 6/10

10% Owner Radoff Bradley Louis sold 115,540 shares ($1.6M) in 4 transactions on 2024-08-26, reducing holdings 88.5% to 15,046 shares

Radoff Bradley Louis, a 10% owner, executed 4 separate sales totaling 115,540 shares for $1,626,419.15 on 2024-08-26, with a blended average price of $14.08. This represents a 88.5% reduction in his pre-transaction holdings (from 130,586 to 15,046 shares), marking a substantial liquidation of his position. The sales occurred at prices well above the current price of $11.45 (which is -36.4% from the 52-week high of $18.00) and represent execution across a narrow price range ($13.54–$15.77), suggesting deliberate allocation over the course of the trading day. His cross-ticker track record shows 10 prior buys with a 100% win rate at 90 days and a +20.2% average 90-day return; however, this sell activity is discrete from that historical pattern and occurs in a stock trading near its 52-week lows, warranting close observation of disclosed rationale and any material developments at the company.

2024-08-15 HARTE HANKS INC HHS
high
Buy
73,900 shares
$533,859
Significance 6/10

Director Radoff bought 73,900 shares over 3 days at blended avg $7.22; holdings jump 30.6% to 315.2K shares

Radoff Bradley Louis, a Director at Harte Hanks, executed 3 separate purchases totaling 73,900 shares for $533,859.21 between August 13–15, 2024, at an average price of $7.22. His post-transaction holdings increased 30.6% to 315.2K shares. This substantial purchase occurs as the stock trades 16.4% below its 52-week high and within his prior same-ticker history where 2 of 2 prior buys at HHS showed positive 90-day returns, establishing a pattern of well-timed entry points at this ticker. However, the company reported a net loss of $27.8M on $45.0M revenue in the latest quarter, with annual revenue declining 7.2%, creating meaningful fundamental headwinds that constrain the signal's weight. The cluster pattern of 2 other insiders also buying within the past 14 days lends incremental credibility to the purchase, but the company's unprofitability and recent equity market underperformance suggest this transaction warrants closer attention to the underlying business trajectory.

high
Buy
352,832 shares
$1,554,160
Significance 7/10

10% owner Radoff Bradley Louis bought 352,832 shares ($1.6M) across 3 trades at $4.35–$4.53, raising stake 20.7% to 2.06M shares

Radoff Bradley Louis, a 10% owner, executed 3 separate purchases totaling 352,832 shares for $1,554,159.86 at a blended average price of $4.40 between August 1–5, 2024. This increased his holdings by 20.7%, from 1,707,168 shares to 2,060,000 shares. The timing coincides with a period where the stock is trading -48.5% from its 52-week high of $8.72, and the company faces headwinds: net income was $-2,376,000.00 over the latest quarter, annual revenue growth declined -4.6%, and the company posted a negative full-year net income. Across his cross-ticker track record, this insider's prior buys showed an average 90-day return of +20.2% with a 100.00% win rate, though same-ticker historical performance is not disclosed. The open-market purchase of a 352.8K block at depressed pricing by a significant shareholder warrants observation of whether the entry signals private conviction about recovery prospects or reflects other strategic considerations.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access